Head-to-head
CoreAge Rx vs NuuVim
CoreAge Rx and NuuVim both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxNuuVim
Ranked #145 · Grade C
Best for: Working moms who want a genuine oral option at the same price as the injectable and are comfortable that the refill-month price isn't published up front.
Visit NuuVimThe verdict
CoreAge Rx edges out NuuVim on the Rx-Readiness Score, 95 to 47 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
NuuVim is still a genuine option — oral access at parity with injectable pricing for both molecules — genuinely uncommon — at a standing $79/$133 new-patient tier, though the follow-on refill rate isn't published and NuuVim's own state coverage couldn't be confirmed live despite WLR's directory claiming all 50 states. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | NuuVim |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 47/100 · C |
| Overall rank | #1 | #145 |
| Semaglutide | $99/mo | $79/mo |
| Tirzepatide | $149/mo | $133/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
NuuVim
Ranked #145 · Grade C
What we like
- Oral access at price parity with injectable for both semaglutide and tirzepatide — a genuinely uncommon menu in this category
- LegitScript-certified and HIPAA-compliant
- The $79/$133 new-patient tier is a standing pricing structure, not a countdown-timer promo
The caveats
- The $79/$133 pricing is explicitly a new-patient tier; NuuVim's own site frames a separate, unpublished 'current user' refill rate as applying afterward
- State coverage could not be independently verified live, despite WLR's directory asserting all 50 states plus DC
- Brand-name Ozempic ($1,498/mo) and Zepbound ($1,892/mo) are priced far above LillyDirect/NovoCare manufacturer self-pay channels
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and NuuVim against other providers on our shortlist.
Or browse the full comparison hub.